Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals is a clinical stage drug development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis (IPF) & chronic cough. The company's business model is highly capital efficient and strives to deliver maximum shareholder value. Algernon's unique approach to drug discovery is based on the concept of drug repurposing.


Recent & Breaking News (CSE:AGN)

Breathtec to Participate in the 2nd Annual RAI$E on the WEST COAST Small-Cap Investing Conference in Vancouver, BC, September 14-15

GlobeNewswire September 14, 2018

Breathtec Provides Nash Pharmaceuticals’ Plans for Next Year

GlobeNewswire September 13, 2018

Data Projects the NASH Market Will Eclipse USD 21 Billion by 2025

PR Newswire August 3, 2018

Breathtec to Open New Drug Development Division, Signs LOI to acquire 100% of Clinical Stage Nash Pharmaceuticals Inc.

GlobeNewswire August 2, 2018

Breathtec Biomedical Announces Appointment of CEO

GlobeNewswire March 1, 2018

Next-Gen Diagnostic Device Moves Closer to Commercialization

Stockhouse Editorial January 26, 2018

UPDATE -- Breathtec Biomedical Provides Development Update on Breathalyzer for Disease Detection

GlobeNewswire January 25, 2018

Breathtec Biomedical Unaware of Any Material Change

GlobeNewswire January 8, 2018

IIROC Trade Resumption - BTH

Canada NewsWire November 14, 2017

Breathtec Biomedical Unaware of Any Material Change

Marketwired November 14, 2017

IIROC Trading Halt - BTH

Canada NewsWire November 14, 2017

Breathtec Biomedical Announces Resignation of Chief Executive Officer

Marketwired September 20, 2017

Pulse Secure Selects Bigtincan AI-Powered Sales Enablement Platform

Business Wire August 15, 2017

Bigtincan Recognized by SIIA as Best Sales Enablement Platform

Business Wire July 31, 2017

Bigtincan Named SIIA Business Technology CODiE Award Finalist for Best Sales Enablement Platform

Business Wire July 13, 2017

Advancements in the early detection of life threatening diseases

Stockhouse Editorial March 17, 2017

Breathtec BioMedical CTO Delivers Presentation to International Science Community

Marketwired March 17, 2017

Breathtec Biomedical Provides Corporate Overview

Marketwired March 1, 2017

Breathtec BioMedical Attends BC Ministers Trade Mission to Israel and Announces Approval of Clinical Trials

Marketwired December 19, 2016

Successful Completion of Private Placement

Marketwired November 28, 2016